An end to the Ebola epidemic in West Africa may be in sight after results from a fast-tracked vaccine trial were described as “hugely important” and “very exciting” by experts. The experimental vaccine VSV-ZEBOV was found to be 100% effective six days after it was administered to 7,651 people living in Guinea, where the virus has already claimed more than 2,500 lives.